Novartis Gets CDSCO Panel nod to study antimalarial drug KLU156 with Coartem Dr. Divya Colin14 Jan 2024 6:00 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Conduct BE and Phase III CT: CDSCO Panel Tells Alkem On Elagolix Tablets Dr. Divya Colin5 May 2023 6:00 PM ISTNew Delhi: In response to the drug major Alkem Laboratories' proposal to manufacture and market the GnRH receptor antagonist Elagolix, the Subject...
Cadila Pharma gets CDSCO panel nod for Phase III CT Of Recombinant Rabies G Protein Vaccine Dr. Divya Colin12 Feb 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug...
Present more data on unmet medical need for Tildrakizumab: CDSCO Panel tells Sun pharma Dr. Divya Colin20 March 2022 12:30 PM ISTNew Delhi: In response to the drug-major Sun Pharma's phase 3 protocol for immunomodulator Tildrakizumab, the Subject Expert Committee (SEC)...
